NDAQ:MNPR - Post Discussion
Post by
whytestocks on May 24, 2024 8:15pm
Monopar Announces CFO Succession
NEWS: $MNPR Monopar Announces CFO SuccessionWILMETTE, Ill., May 24, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that after a career spanning more than 35 years, Monopar’s Chief Financia...
MNPR - Monopar Announces CFO Succession
Be the first to comment on this post